Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC. | Cancers (Basel) | 2023 | 38067293 | PubTator, text mining | PubMed |
| An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma. | Heliyon | 2023 | 38053861 | PubTator, text mining | PubMed |
| Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings. | BMC Urol | 2023 | 38049825 | PubTator, text mining | PubMed |
| MESPool: Molecular Edge Shrinkage Pooling for hierarchical molecular representation learning and property prediction. | Brief Bioinform | 2023 | 38048081 | PubTator, text mining | PubMed |
| Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent. | Int J Mol Sci | 2023 | 38003585 | PubTator, text mining | PubMed |
| Current Knowledge about the Peritumoral Microenvironment in Glioblastoma. | Cancers (Basel) | 2023 | 38001721 | PubTator, text mining | PubMed |
| Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma. | World J Surg Oncol | 2023 | 38001498 | PubTator, text mining | PubMed |
| PBK correlates with prognosis, immune escape and drug response in LUAD. | Sci Rep | 2023 | 37993518 | PubTator, text mining | PubMed |
| Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 37986299 | PubTator, text mining | PubMed |
| Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032. | Int J Mol Sci | 2023 | 37958502 | PubTator, text mining | PubMed |
| The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia. | Cancers (Basel) | 2023 | 37958340 | PubTator, text mining | PubMed |
| Targeting of intracellular oncoproteins with peptide-centric CARs. | Nature | 2023 | 37938771 | PubTator, text mining | PubMed |
| Correction: PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma. | Oncogenesis | 2023 | 37938233 | PubTator, text mining | PubMed |
| Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. | J Transl Med | 2023 | 37932756 | PubTator, text mining | PubMed |
Identification of MARK2, CCDC71, GATA2, and KLRC3 as candidate diagnostic genes and potential therapeutic targets for repeated implantation failure with antiphospholipid syndrome by integrated bioinformatics analysis and machine learning. | Front Immunol | 2023 | 37901230 | PubTator, text mining | PubMed |
| The Combination of a Graph Neural Network Technique and Brain Imaging to Diagnose Neurological Disorders: A Review and Outlook. | Brain Sci | 2023 | 37891830 | PubTator, text mining | PubMed |
| A novel prognostic N7-methylguanosine-related long non-coding RNA signature in clear cell renal cell carcinoma. | Sci Rep | 2023 | 37891201 | PubTator, text mining | PubMed |
| Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis. | Mol Cell Proteomics | 2023 | 37866481 | PubTator, text mining | PubMed |
| Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer. | Cancer Cell Int | 2023 | 37858151 | PubTator, text mining | PubMed |
| Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency. | J Ovarian Res | 2023 | 37848988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=9